Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2015
At a glance
- Drugs Becaplermin (Primary) ; Plerixafor (Primary)
- Indications Diabetic foot ulcer
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 25 Apr 2013 Planned End Date changed from 1 Dec 2012 to 1 Sep 2016 as reported by ClinicalTrials.gov.
- 25 Apr 2013 Planned initiation date changed from 1 Jan 2012 to 1 Apr 2014 as reported by ClinicalTrials.gov.